Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Palladium Network Palladium Network +6.43%
#3 Cryptopia Cryptopia +4.36%
#4 SIXSEVEN SIXSEVEN +4.11%
#5 Kinetiq Kinetiq +3.41%
#6 Test Test +3.32%
#7 Movement Movement +3.31%
#8 Victoria VR Victoria VR +3.17%
#9 Jito Jito +3.05%
#10 COTI COTI +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Clasificación en acciones #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$7.87K
Cambio (1 día)
0.00%
Cambio (1 año)
-50.00%
País
US
Comercio Biostax Corp. (BTAX)

Categoría

Healthcare
Precio BTAX con Capital del mercado a B
Biostax Corp. Biostax Corp.
BTAX
$0.0001
Capitalización de mercado de Biostax Corp.(BTAX)
Capitalización bursátil: $7.87K
A fecha de August 2026, Biostax Corp. tiene una capitalización de mercado de $7.87K. Esto convierte a Biostax Corp. en la 41904th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Biostax Corp. desde 2010 hasta 2026
BTAX en comparación con los más populares 5 títulos stocks
Precio por BTAX Activo B Capital del mercado en B Resultados
Biostax Corp. Biostax Corp.
$68,394.86 $7.87K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +68,394,860,273.52%
Biostax Corp. Biostax Corp.
$56,198.59 $7.87K
Apple Inc. Apple Inc.
AAPL
$4.423T +56,198,592,248.34%
Biostax Corp. Biostax Corp.
$52,856.94 $7.87K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +52,856,935,474.67%
Biostax Corp. Biostax Corp.
$46,542.00 $7.87K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +46,542,000,115.98%
Biostax Corp. Biostax Corp.
$36,732.67 $7.87K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +36,732,674,215.84%